Apexium Financial, LP Mannkind Corp Transaction History
Apexium Financial, LP
- $1.71 Billion
- Q2 2025
A detailed history of Apexium Financial, LP transactions in Mannkind Corp stock. As of the latest transaction made, Apexium Financial, LP holds 23,250 shares of MNKD stock, worth $129,037. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,250
Previous 23,250
-0.0%
Holding current value
$129,037
Previous $116,000
25.86%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding MNKD
# of Institutions
251Shares Held
161MCall Options Held
1.24MPut Options Held
183K-
Black Rock Inc. New York, NY22.6MShares$125 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$101 Million0.0% of portfolio
-
State Street Corp Boston, MA10.7MShares$59.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.62MShares$42.3 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY7.01MShares$38.9 Million4.77% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.43B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...